ReviewCancers2024

The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy.

Haokang Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.